Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs. Sevoflurane for Recovery After Cervical Spine Surgery
NCT05019222Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Sep 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam (2 arms), sponsored by Gangnam Severance Hospital. Primary endpoint: Quality of Recovery-15. Started Sep 2021; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05019222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05019222.